Clinical Trials Updated in 2014

NCT00535132 | COMPLETED | PHASE4

201 participants

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2007-10-31
Completion:: 2008-07-31

Conditions

Schizophrenia

Interventions

DRUG

Results Available

NCT00529555 | COMPLETED | PHASE3

602 participants

Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-01-31
Completion:: 2008-12-31

Conditions

Adult Periodontitis

Interventions

DRUG
PROCEDURE

Results Available

NCT00492089 | COMPLETED | PHASE2

11 participants

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2007-06-30
Completion:: 2010-08-31

Conditions

Adult Anaplastic Astrocytoma
Adult Anaplastic Ependymoma
Adult Anaplastic Meningioma
Adult Anaplastic Oligodendroglioma
Adult Brain Stem Glioma
Adult Central Nervous System Germ Cell Tumor
Adult Choroid Plexus Tumor
Adult Diffuse Astrocytoma
Adult Ependymoma
Adult Grade II Meningioma
Adult Grade III Meningioma
Adult Malignant Hemangiopericytoma
Adult Mixed Glioma
Adult Oligodendroglioma
Adult Papillary Meningioma
Adult Pineocytoma
Malignant Neoplasm
Meningeal Melanocytoma
Radiation Toxicity
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
Recurrent Adult Brain Tumor
Recurrent Basal Cell Carcinoma of the Lip
Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity
Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity
Recurrent Lymphoepithelioma of the Nasopharynx
Recurrent Lymphoepithelioma of the Oropharynx
Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity
Recurrent Mucoepidermoid Carcinoma of the Oral Cavity
Recurrent Salivary Gland Cancer
Recurrent Squamous Cell Carcinoma of the Hypopharynx
Recurrent Squamous Cell Carcinoma of the Larynx
Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity
Recurrent Squamous Cell Carcinoma of the Nasopharynx
Recurrent Squamous Cell Carcinoma of the Oropharynx
Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
Recurrent Verrucous Carcinoma of the Larynx
Recurrent Verrucous Carcinoma of the Oral Cavity
Stage I Adenoid Cystic Carcinoma of the Oral Cavity
Stage I Basal Cell Carcinoma of the Lip
Stage I Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity
Stage I Inverted Papilloma of the Paranasal Sinus and Nasal Cavity
Stage I Lymphoepithelioma of the Nasopharynx
Stage I Lymphoepithelioma of the Oropharynx
Stage I Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity
Stage I Mucoepidermoid Carcinoma of the Oral Cavity
Stage I Salivary Gland Cancer
Stage I Squamous Cell Carcinoma of the Hypopharynx
Stage I Squamous Cell Carcinoma of the Larynx
Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity
Stage I Squamous Cell Carcinoma of the Nasopharynx
Stage I Squamous Cell Carcinoma of the Oropharynx
Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
Stage I Verrucous Carcinoma of the Larynx
Stage I Verrucous Carcinoma of the Oral Cavity
Stage III Adenoid Cystic Carcinoma of the Oral Cavity
Stage III Basal Cell Carcinoma of the Lip
Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity
Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity
Stage III Lymphoepithelioma of the Nasopharynx
Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity
Stage III Mucoepidermoid Carcinoma of the Oral Cavity
Stage III Salivary Gland Cancer
Stage III Squamous Cell Carcinoma of the Hypopharynx
Stage III Squamous Cell Carcinoma of the Larynx
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
Stage III Squamous Cell Carcinoma of the Nasopharynx
Stage III Squamous Cell Carcinoma of the Oropharynx
Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
Stage III Verrucous Carcinoma of the Larynx
Stage III Verrucous Carcinoma of the Oral Cavity
Stage IV Adenoid Cystic Carcinoma of the Oral Cavity
Stage IV Basal Cell Carcinoma of the Lip
Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity
Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity
Stage IV Lymphoepithelioma of the Nasopharynx
Stage IV Lymphoepithelioma of the Oropharynx
Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity
Stage IV Mucoepidermoid Carcinoma of the Oral Cavity
Stage IV Salivary Gland Cancer
Stage IV Squamous Cell Carcinoma of the Hypopharynx
Stage IV Squamous Cell Carcinoma of the Larynx
Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity
Stage IV Squamous Cell Carcinoma of the Nasopharynx
Stage IV Squamous Cell Carcinoma of the Oropharynx
Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
Stage IV Verrucous Carcinoma of the Larynx
Stage IV Verrucous Carcinoma of the Oral Cavity

Interventions

DRUG
PROCEDURE

Results Available

NCT00487435 | COMPLETED | PHASE3

1166 participants

An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2007-06-30
Completion:: 2009-06-30

Conditions

Pain
Osteoarthritis
Low Back Pain

Interventions

DRUG

Results Available

NCT00412373 | COMPLETED | PHASE3

307 participants

Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-12-31
Completion:: 2008-06-30

Conditions

Schizoaffective Disorder
Psychotic Disorder

Interventions

DRUG

Results Available

NCT00404651 | COMPLETED | PHASE3

1189 participants

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-11-30
Completion:: 2008-04-30

Conditions

Diphtheria
Tetanus
Pertussis
Hepatitis B
Poliomyelitis

Interventions

BIOLOGICAL

Results Available

NCT00392314 | COMPLETED | PHASE2

365 participants

Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-10-31
Completion:: 2014-05-31

Conditions

Hodgkin Lymphoma

Interventions

OTHER

No Results Yet

NCT00391222 | COMPLETED | PHASE3

585 participants

A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-11-30
Completion:: 2009-04-30

Conditions

Bipolar Disorder

Interventions

DRUG

Results Available

NCT00369746 | COMPLETED

674 participants

STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse

Study Type:: OBSERVATIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-09-30
Completion:: 2009-02-28

Conditions

Major Depressive Disorder
Alcohol Use Disorder

Interventions

DRUG

Results Available

NCT00343811 | COMPLETED | PHASE3

120 participants

Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-06-30

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

No Results Yet

NCT00343733 | COMPLETED | PHASE3

120 participants

Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-08-31

Conditions

Pain

Interventions

DRUG

No Results Yet

NCT00326443 | COMPLETED | PHASE1

21 participants

CVD 909 Vi Prime Boost Study

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-02-28
Completion:: 2007-09-30

Conditions

Typhoid Fever

Interventions

BIOLOGICAL
DRUG

No Results Yet

NCT00315250 | COMPLETED | PHASE2

225 participants

Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-01-31
Completion:: 2010-01-31

Conditions

Parkinson's Disease
Parkinsonian Syndrome

Interventions

DRUG

No Results Yet

NCT00290810 | COMPLETED | PHASE2

12 participants

Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-12-31
Completion:: 2008-10-31

Conditions

B-cell Chronic Lymphocytic Leukemia
Refractory Chronic Lymphocytic Leukemia

Interventions

BIOLOGICAL

Results Available

NCT00290719 | TERMINATED | PHASE1

6 participants

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-11-30
Completion:: 2008-04-30

Conditions

Esophageal Cancer

Interventions

DRUG
PROCEDURE
RADIATION

No Results Yet

NCT00273351 | COMPLETED | PHASE2

62 participants

Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-01-31
Completion:: 2008-01-31

Conditions

Parkinson Disease
Parkinsonian Syndrome

Interventions

DRUG

No Results Yet

NCT00236093 | COMPLETED | PHASE2

Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2006-10-31
Completion:: 2006-12-31

Conditions

Pain
Cancer
Sickle Cell Anemia
Severe Burns

Interventions

DRUG

No Results Yet

NCT00236067 | COMPLETED | PHASE3

440 participants

A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2004-10-31

Conditions

Generalized Anxiety Disorder

Interventions

DRUG

No Results Yet

NCT00236054 | COMPLETED | PHASE3

440 participants

A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2004-10-31

Conditions

Generalized Anxiety Disorder

Interventions

DRUG

No Results Yet

NCT00236041 | COMPLETED | PHASE2

38 participants

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2004-04-30

Conditions

Cancer
Breakthrough Pain

Interventions

DRUG

No Results Yet

NCT00236015 | COMPLETED | PHASE3

880 participants

A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2004-11-30

Conditions

Anxiety Disorder

Interventions

DRUG

No Results Yet

NCT00228605 | COMPLETED | PHASE3

500 participants

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-03-31

Conditions

Low Back Pain
Migraine
Diabetic Neuropathies
Osteoarthritis

Interventions

DRUG

No Results Yet

NCT00228540 | COMPLETED | PHASE3

Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-09-30

Conditions

ADHD

Interventions

DRUG

No Results Yet

NCT00214994 | COMPLETED | PHASE3

Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-01-31

Conditions

Anxiety Disorders

Interventions

DRUG

No Results Yet

NCT00214955 | COMPLETED | PHASE3

120 participants

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-09-30
Completion:: 2006-05-31

Conditions

Chronic Neuropathic Pain

Interventions

DRUG

No Results Yet

NCT00214942 | COMPLETED | PHASE3

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-09-30
Completion:: 2006-03-31

Conditions

Chronic Low Back Pain

Interventions

DRUG

No Results Yet

NCT00208091 | COMPLETED | PHASE4

16 participants

Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2003-04-30
Completion:: 2008-05-31

Conditions

Focal Dystonia

Interventions

DRUG

Results Available

NCT00139841 | COMPLETED | PHASE3

103 participants

Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-10-31
Completion:: 2007-07-31

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG

No Results Yet

NCT00138476 | COMPLETED | PHASE1

57 participants

New Challenge Pool of Norwalk Virus Inoculum

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2004-08-31
Completion:: 2012-04-30

Conditions

Gastroenteritis Norovirus

Interventions

DRUG
BIOLOGICAL

No Results Yet

NCT00121420 | TERMINATED | PHASE2

45 participants

Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09

Conditions

Neoplasm Metastasis
Brain Neoplasms

Interventions

DRUG

No Results Yet

NCT00117481 | COMPLETED | PHASE2

90 participants

Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-06-30
Completion:: 2007-12-31

Conditions

Endometriosis

Interventions

DRUG
OTHER

No Results Yet

NCT00117273 | COMPLETED | PHASE3

36 participants

A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-06-30

Conditions

Healthy

Interventions

DRUG

No Results Yet

NCT00110214 | COMPLETED | PHASE3

1050 participants

Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-04-30
Completion:: 2010-03-31

Conditions

Adenocarcinoma of the Prostate
Hormone-resistant Prostate Cancer
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG
OTHER
BIOLOGICAL

Results Available

NCT00107848 | COMPLETED | PHASE3

280 participants

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2004-10-31

Conditions

Narcolepsy
Sleep Apnea, Obstructive

Interventions

DRUG

No Results Yet

NCT00107809 | COMPLETED | PHASE3

140 participants

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2004-10-31

Conditions

Sleep Apnea, Obstructive

Interventions

DRUG

No Results Yet

NCT00105287 | COMPLETED | PHASE3

100 participants

Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2005-01-31
Completion:: 2006-09-30

Conditions

Pain
Cancer

Interventions

DRUG

No Results Yet

NCT00087139 | COMPLETED | PHASE2

124 participants

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2004-09-30
Completion:: 2009-04-30

Conditions

Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG

Results Available

NCT00076349 | COMPLETED | PHASE2

66 participants

SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2004-04-30
Completion:: 2005-12-31

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG

No Results Yet

NCT00069758 | COMPLETED | PHASE2

72 participants

Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2003-09-30
Completion:: 2007-04-30

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG

No Results Yet

NCT00056563 | COMPLETED | PHASE3

255 participants

Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial

Study Type:: INTERVENTIONAL
Last Updated:: 2014-05-09
Start Date:: 2002-04-30
Completion:: 2008-10-31

Conditions

Parkinson's Disease

Interventions

DEVICE
OTHER

Results Available